Evidence map›Paper›PMID 40333758›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Interferon-induced activation of dendritic cells and monocytes by yellow fever vaccination correlates with early antibody responses.

Elena Winheim, Antonio Santos-Peral, Tamara Ehm, Linus Rinke, Sandra Riemer, Magdalena Zaucha, Sebastian Goresch, Lisa Lehmann, Katharina Eisenächer, Michael Pritsch and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Elena WinheimInstitute for Immunology, Biomedical Center, Faculty of Medicine, LMU, Munich D-82152, Germany.ORCID 0000-0002-0364-662X
Antonio Santos-PeralDivision of Clinical Pharmacology, University Hospital, Ludwig-Maximilans-Universität München, Munich D-80336, Germany.
Tamara EhmInstitute for Immunology, Biomedical Center, Faculty of Medicine, LMU, Munich D-82152, Germany.
Linus RinkeInstitute for Immunology, Biomedical Center, Faculty of Medicine, LMU, Munich D-82152, Germany.ORCID 0000-0002-7563-7116
Sandra RiemerInstitute for Immunology, Biomedical Center, Faculty of Medicine, LMU, Munich D-82152, Germany.ORCID 0009-0008-8866-4659
Magdalena ZauchaDivision of Clinical Pharmacology, University Hospital, Ludwig-Maximilans-Universität München, Munich D-80336, Germany.
Sebastian GoreschDivision of Clinical Pharmacology, University Hospital, Ludwig-Maximilans-Universität München, Munich D-80336, Germany.ORCID 0009-0006-3586-6498
Lisa LehmannDivision of Clinical Pharmacology, University Hospital, Ludwig-Maximilans-Universität München, Munich D-80336, Germany.ORCID 0000-0002-5153-3371
Katharina EisenächerInstitute for Immunology, Biomedical Center, Faculty of Medicine, LMU, Munich D-82152, Germany.
Michael PritschDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU, Munich D-80802, Germany.
Giovanna Barba-SpaethInstitut Pasteur, Université Paris Cité, CNRS UMR 3569, Unité de Virologie Structurale, Paris 75724, France.
Tobias StraubCore Facility Bioinformatics, Biomedical Center, Faculty of Medicine, LMU, Munich D-82152, Germany.
Simon RothenfusserDivision of Clinical Pharmacology, University Hospital, Ludwig-Maximilans-Universität München, Munich D-80336, Germany.
Anne B KrugInstitute for Immunology, Biomedical Center, Faculty of Medicine, LMU, Munich D-82152, Germany.ORCID 0000-0002-9556-7207

Funding

Agence Nationale de la Recherche (ANR) ANR-17-CE15-0031-01Deutsche Forschungsgemeinschaft (DFG) 210592381Deutsche Forschungsgemeinschaft (DFG) 369799452Deutsche Forschungsgemeinschaft (DFG) 391217598EC | HORIZON EUROPE Framework Programme (Horizon Europe) 101137459Evangelisches Studienwerk Villigst (Protestant Academic Foundation) Scholarship EWFriedrich-Baur-Stiftung (Friedrich Baur Stiftung) EWHelmholtz Zentrum München (Helmholtz Centre Munich, German Research Center for Environmental Health) iMed
6 · The paper itself

Abstract

Yellow fever vaccination provides long-lasting protection and is a unique model for studying the immune response to an acute RNA virus infection in humans. To elucidate the early innate immune events preceding the rapid generation of protective immunity, we performed transcriptome analysis of human blood dendritic cell (DC) and monocyte subpopulations before and 3, 7, 14, and 28 d after vaccination. We detected temporary upregulation of IFN-stimulated genes (ISG) in all DC and monocyte subsets on days 3 and 7 after vaccination as well as cell type-specific responses and response kinetics. Single-cell RNA sequencing revealed rapid appearance of activated DC and monocyte clusters dominated by ISGs, inflammatory chemokines, and genes involved in antigen processing and presentation. This was confirmed by flow cytometric analysis in a large cohort of vaccinees. We identified SIGLEC1/CD169 upregulation as a sensitive indicator of the transient IFN-induced activation state elicited in DCs and monocytes by YF17D vaccination correlating with early protective IgM antibody responses.

Indexed as

Antibodies, ViralAntibody FormationDendritic CellsInterferonsMonocytesYellow FeverYellow Fever VaccineHumansSialic Acid Binding Ig-like Lectin 1Single-Cell AnalysisVaccinationYellow fever virusAntibodies, ViralInterferonsSialic Acid Binding Ig-like Lectin 1SIGLEC1 protein, humanYellow Fever Vaccinedendritic cellsinterferonmonocytesvaccinationyellow fever virus

Identifiers

PMID40333758
PMCPMC12088451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.